Observational studyThe Journal of international medical research2026
Tacrolimus intrapatient variability and latent virus reactivation after kidney transplantation: A retrospective study comparing prolonged-release and immediate-release tacrolimus formulations.
Observational study in The Journal of international medical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
ObjectiveThis study explored the differences in intrapatient variability of tacrolimus between prolonged-release and immediate-release formulations and evaluated the association between tacrolimus intrapatient variability and reactivation of BK virus and cytomegalovirus in kidney transplant recipients.MethodsThis retrospective observational study included 270 kidney transplant recipients receiving either prolonged-release tacrolimus or immediate-release tacrolimus. Receiver operating characteristic curve analysis identified tacrolimus intrapatient variability cutoff values associated with viral reactivation. Logistic regression analyses identified predictors of BK virus and cytomegalovirus reactivation.ResultsThe prolonged-release tacrolimus group had significantly lower tacrolimus intrapatient variability than the immediate-release tacrolimus group (p < 0.001). No significant differences were observed in BK virus and cytomegalovirus reactivation rates. Receiver operating characteristic curve analysis identified tacrolimus intrapatient variability cutoffs of 0.268 for BK virus and 0.261 for cytomegalovirus. High tacrolimus intrapatient variability was significantly associated with increased BK virus and cytomegalovirus reactivation. Logistic regression showed that high tacrolimus intrapatient variability was significantly associated with BK virus and cytomegalovirus reactivation. Multivariate analysis confirmed an independent association between high tacrolimus intrapatient variability and cytomegalovirus reactivation.ConclusionsTacrolimus intrapatient variability may predict reactivation of latent viral infection after kidney transplantation. Although viral reactivation rates were similar between tacrolimus formulations, prolonged-release tacrolimus showed lower tacrolimus intrapatient variability levels, suggesting that fluctuations in tacrolimus exposure might increase the risk of viral reactivation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.